BioSpace News Archive

Certa Therapeutics’ investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases

New research presented today by the University of Michigan reveals ground-breaking results for Certa Therapeutics’ FT011, a novel potential treatment of serious inflammatory and fibrotic diseases.

November 3, 2022
·
6 min read
Business

Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights

Relay Therapeutics, Inc. reported third quarter 2022 financial results and recent corporate highlights.

November 3, 2022
·
8 min read
Business

Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update

Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported financial results for the third quarter ended September 30, 2022 and reviewed business highlights.

November 3, 2022
·
12 min read
Business

RVL Pharmaceuticals plc to Discuss Third Quarter 2022 Financial Results and Provide Commercial Update

RVL Pharmaceuticals plc announced that the Company will release its third quarter 2022 financial results and provide a commercial update on Thursday, November 10, 2022, after the close of the U.S. financial markets.

November 3, 2022
·
3 min read
BioMidwest

Axogen to Participate at Upcoming Investor Conferences - November 03, 2022

Axogen, Inc. announced that Karen Zaderej, chairman, CEO, and president, and Peter Mariani, executive vice president and CFO will participate in upcoming investor conferences in November and December.

November 3, 2022
·
2 min read
Freeline Reports October 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 03, 2022

Freeline Therapeutics Holdings plc announced that on October 31, 2022, the Company granted three newly hired employees non-statutory options to purchase an aggregate of 75,500 of the Company’s ordinary shares.

November 3, 2022
·
1 min read
BioMidwest

Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference

Stryker will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.

November 3, 2022
·
1 min read
Business

Corcept Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Corcept Therapeutics Incorporated, a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol, reported its results for the quarter ended September 30, 2022.

November 3, 2022
·
11 min read
Business

Codexis Reports Third Quarter 2022 Financial Results

Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced financial results for the third quarter ended September 30, 2022 and provided a business update.

November 3, 2022
·
12 min read
Business

Miromatrix to Report Third Quarter 2022 Financial Results

Miromatrix Medical Inc. announced that the Company will report financial results for the third quarter 2022 after market close on Monday, November 14, 2022.

November 3, 2022
·
1 min read